ImmunoGen Message Board - Msg: 28567348

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Gary Mohilner	11/25/2012 5:32:26 PM
	Read Replies (1) of 5665

I believe we could see approval of T-DM1 well before the PDUFA date, perhaps this year. While the low royalties hurt, this is still a huge step in the right direction. It's very possible that other events will have an even greater effect on IMGN, hopefully starting to learn more about other pipeline drugs in the next several weeks at one of several technical conferences before year's end. While I still believe IMGN will earn hundreds of millions annually from T-DM1 sales. In time, earning billions annually will be anticipated as other drugs approach approval. For now we wait and see what they may be. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next